MUMBAI, India, Oct. 11 -- Intellectual Property India has published a patent application (202411019977 A) filed by Indian Council Of Medical Research, New Delhi, on March 18, 2024, for 'an intravenous pharmaceutical medicament for candidiasis infection.'
Inventor(s) include Thomas, Susan Idicula; Chakraborty, Shuvechha; Madan, Taruna; and Metkari, Siddhanath Maruti.
The application for the patent was published on Oct. 10, under issue no. 41/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to pharmaceutical medicament or composition or formulation. Particularly, the present invention relates an intravenous medicament of besifloxacin hydrochloride and pharmaceutically acceptable ex...